Literature DB >> 2191175

Pathophysiological role of endothelin in acute renal failure.

Y Shibouta1, N Suzuki, A Shino, H Matsumoto, Z Terashita, K Kondo, K Nishikawa.   

Abstract

In conscious rats, the i.v. injection of endothelin (ET) caused an increase in blood urea nitrogen (BUN), an index of renal dysfunction. In the model of acute renal failure which was induced by occlusion of the bilateral renal arteries of rats followed by reperfusion, ET-monoclonal antibody improved the renal function. In this model, ET-antibody also protected the kidneys from renal proximal tubular necrosis and suppressed Ca++-accumulation in necrotic tissues. Plasma ET level increased 5 min and 5 hr and renal ET content did 5 and 20 hr after reperfusion. BUN level increased 5 and 20 hr after reperfusion. These results strongly suggest that the endogenously increased ET may be one of the important deleterious mediators in the pathogenesis of ischemic acute renal failure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2191175     DOI: 10.1016/0024-3205(90)90392-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  19 in total

1.  Modeling and docking the endothelin G-protein-coupled receptor.

Authors:  A J Orry; B A Wallace
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, AwETN40.

Authors:  A Urakami; S Todo; Y Zhu; S Zhang; M B Jin; N Ishizaki; T Shimamura; E Totsuka; V Subbotin; R Lee; T E Starzl
Journal:  J Am Coll Surg       Date:  1997-10       Impact factor: 6.113

Review 3.  Endothelins. Vascular actions and clinical implications.

Authors:  T Sakurai; K Goto
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

4.  RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury.

Authors:  Andrew M Siedlecki; Xiaohua Jin; Winston Thomas; Keith A Hruska; Anthony J Muslin
Journal:  Kidney Int       Date:  2011-03-16       Impact factor: 10.612

Review 5.  The clinical potential of endothelin receptor antagonists in cardiovascular medicine.

Authors:  C J Ferro; D J Webb
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

6.  Protective effect of milk fat globule-epidermal growth factor-factor VIII after renal ischemia-reperfusion injury in mice.

Authors:  Akihisa Matsuda; Rongqian Wu; Asha Jacob; Hidefumi Komura; Mian Zhou; Zhimin Wang; Md Monowar Aziz; Ping Wang
Journal:  Crit Care Med       Date:  2011-09       Impact factor: 7.598

7.  Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats.

Authors:  J Conger; J Robinette; A Villar; L Raij; P Shultz
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Comparison of haemoconcentration induced by big endothelin-1 and endothelin-1 in mice.

Authors:  H Okumura; N Ashizawa; F Kobayashi; K Arai; R Asakura; N Ashikawa; A Matsuura
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

9.  Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression.

Authors:  J D Firth; P J Ratcliffe
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  Fenoldopam use in a burn intensive care unit: a retrospective study.

Authors:  John W Simmons; Kevin K Chung; Evan M Renz; Christopher E White; Casey L Cotant; Molly A Tilley; Mark O Hardin; John A Jones; Lorne H Blackbourne; Steven E Wolf
Journal:  BMC Anesthesiol       Date:  2010-06-24       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.